乳房手术围术期动静脉血栓栓塞预防的系统综述与meta分析
该系统综述与meta分析纳入5617例女性乳房手术患者,比较术前、术中及/或术后药物性预防与非药物性预防对结局和并发症的影响。共11项研究符合纳入标准,分析117个结局中的26个。结果显示药物性预防未显著降低深静脉血栓和/或肺栓塞,也未显著增加血肿,但术中药物性预防与更多再手术和出血相关,术后药物性预防与更多出血相关。
要点
- 乳房手术药物性血栓预防未显著降低深静脉血栓/肺栓塞风险。
- 术中药物性预防与更多再手术及出血事件相关。
- 术后药物性预防与更多出血事件相关,需权衡出血风险。
核心结论
- 乳房手术患者围术期药物性血栓预防未显著降低深静脉血栓和/或肺栓塞,也未显著增加血肿。
- 术中药物性预防与更多再手术和任何出血相关,术后药物性预防与更多任何出血相关。
研究设计与样本
- 系统综述与meta分析,纳入11项研究,共5617例女性乳房手术患者。
- 检索PubMed、EMBASE、Cochrane Library、Web of Science和Google Scholar数据库。
- 遵循PRISMA和Cochrane指南,分析117个可能结局中的26个。
主要发现
- 接受术中药物性预防的患者再手术和任何出血的发生率更高。
- 接受术后药物性预防的患者任何出血的发生率高于非药物性预防。
- 合并糖尿病者更可能接受术前药物性预防,BMI较高者更可能接受术后药物性预防。
- 药物性预防组与非药物性预防组在深静脉血栓和/或肺栓塞及血肿方面无显著差异。
临床怎么用
- 乳房手术围术期药物性血栓预防需个体化评估出血与血栓风险。
- 术中或术后药物性预防可能增加出血相关事件,应加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Both thromboembolism and excessive bleeding following breast surgery could result in multiple surgical procedures, breast reconstruction failure, or even mortality. This systematic review and meta-analysis of 5617 female breast surgery patients compared pharmacological prophylaxis to nonpharmacological prophylaxis interventions during the pre-, intra-, and/or postoperative time points and evaluated associated outcomes and complications. The PubMed, EMBASE, Cochrane Library, Web of Science, and Google Scholar databases were systematically and independently searched. Patient and clinical characteristics, surgical and medical interventions, outcomes, and complications were recorded. Eleven of the 344 studies queried were eligible for systematic review and meta-analysis, with results from 26 of the possible 117 outcomes and complications using strict PRISMA and Cochrane guidelines. Patients receiving intraoperative pharmacological prophylaxis for breast surgery were found to have more reoperations and more occurrences of any bleeding, while patients receiving postoperative pharmacological prophylaxis were found to have more occurrences of any bleeding than patients receiving nonpharmacological prophylaxis. Patients were more likely to receive preoperative pharmacological prophylaxis if they had diabetes mellitus and postoperative chemoprophylaxis if they had higher BMIs. Patients administered pharmacological prophylaxis during the pre-, intra-, and/or postoperative time periods did not show a significant decrease in deep vein thrombosis and/or pulmonary embolism or increase in hematomas compared to those administered nonpharmacological prophylaxis.
引用
- Klifto KM, Gurno CF, Major M, et al. Pre-, intra-, and/or postoperative arterial and venous thromboembolism prophylaxis for breast surgery: Systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2019. PMID: 31718992. doi:10.1016/j.bjps.2019.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。